Mink Accounts Payable vs Net Debt Analysis

INKT Stock  USD 0.98  0.02  1.98%   
Mink Therapeutics financial indicator trend analysis is infinitely more than just investigating Mink Therapeutics recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Mink Therapeutics is a good investment. Please check the relationship between Mink Therapeutics Accounts Payable and its Net Debt accounts. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Mink Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in industry.
For more information on how to buy Mink Stock please use our How to Invest in Mink Therapeutics guide.

Accounts Payable vs Net Debt

Accounts Payable vs Net Debt Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Mink Therapeutics Accounts Payable account and Net Debt. At this time, the significance of the direction appears to have strong contrarian relationship.
The correlation between Mink Therapeutics' Accounts Payable and Net Debt is -0.65. Overlapping area represents the amount of variation of Accounts Payable that can explain the historical movement of Net Debt in the same time period over historical financial statements of Mink Therapeutics, assuming nothing else is changed. The correlation between historical values of Mink Therapeutics' Accounts Payable and Net Debt is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Accounts Payable of Mink Therapeutics are associated (or correlated) with its Net Debt. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Net Debt has no effect on the direction of Accounts Payable i.e., Mink Therapeutics' Accounts Payable and Net Debt go up and down completely randomly.

Correlation Coefficient

-0.65
Relationship DirectionNegative 
Relationship StrengthWeak

Accounts Payable

An accounting item on the balance sheet that represents Mink Therapeutics obligation to pay off a short-term debt to its creditors. The accounts payable entry is usually reported under current liabilities. If accounts payable of Mink Therapeutics are not paid within the agreed terms, the payables are considered to be in default, which may trigger a penalty or interest payment, or the revocation of additional credit from the supplier. Accounts payable may also be considered a source of cash, since they represent funds being borrowed from suppliers. Given these cash flow considerations, suppliers have a natural inclination to push for shorter payment terms, while creditors want to lengthen the payment terms. The amount a company owes to suppliers or vendors for products or services received but not yet paid for. It represents the company's short-term liabilities.

Net Debt

The total debt of a company minus its cash and cash equivalents. It represents the actual debt burden on the company after accounting for the liquid assets it holds.
Most indicators from Mink Therapeutics' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Mink Therapeutics current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Mink Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in industry.
For more information on how to buy Mink Stock please use our How to Invest in Mink Therapeutics guide.Selling General Administrative is likely to drop to about 5.5 M in 2024. Issuance Of Capital Stock is likely to drop to 0.00 in 2024
 2021 2022 2023 2024 (projected)
Interest Expense2.4M253.3K228.0K216.6K
Depreciation And Amortization299.9K121.7K204.6K256.1K

Mink Therapeutics fundamental ratios Correlations

0.590.720.760.91-0.610.790.480.05-0.87-0.450.451.00.480.591.0-0.610.1-0.75-0.140.930.72-0.640.910.441.0
0.590.910.880.57-0.970.670.83-0.44-0.67-0.860.750.580.831.00.58-0.970.47-0.610.210.660.86-0.430.230.860.57
0.720.910.990.61-0.950.670.63-0.4-0.68-0.720.590.710.630.910.71-0.950.47-0.550.320.850.75-0.360.450.640.72
0.760.880.990.65-0.950.70.64-0.4-0.72-0.730.630.750.640.880.75-0.950.5-0.590.270.90.76-0.40.490.640.75
0.910.570.610.65-0.590.960.64-0.2-0.99-0.630.540.910.640.570.91-0.590.33-0.95-0.490.840.86-0.90.740.610.9
-0.61-0.97-0.95-0.95-0.59-0.69-0.810.530.690.87-0.78-0.6-0.81-0.97-0.61.0-0.590.61-0.23-0.75-0.840.43-0.26-0.83-0.6
0.790.670.670.70.96-0.690.75-0.47-0.98-0.80.610.80.750.670.8-0.690.56-0.98-0.490.790.93-0.930.530.750.78
0.480.830.630.640.64-0.810.75-0.52-0.75-0.940.950.471.00.830.47-0.810.58-0.77-0.210.510.92-0.680.080.990.46
0.05-0.44-0.4-0.4-0.20.53-0.47-0.520.340.75-0.410.05-0.52-0.440.050.53-0.970.410.19-0.2-0.490.40.39-0.560.07
-0.87-0.67-0.68-0.72-0.990.69-0.98-0.750.340.75-0.65-0.87-0.75-0.67-0.870.69-0.450.970.45-0.84-0.930.91-0.63-0.73-0.86
-0.45-0.86-0.72-0.73-0.630.87-0.8-0.940.750.75-0.83-0.44-0.94-0.86-0.440.87-0.780.780.19-0.56-0.920.68-0.03-0.96-0.43
0.450.750.590.630.54-0.780.610.95-0.41-0.65-0.830.440.950.750.44-0.780.52-0.63-0.080.520.8-0.520.090.890.44
1.00.580.710.750.91-0.60.80.470.05-0.87-0.440.440.470.581.0-0.60.1-0.76-0.160.930.71-0.650.910.441.0
0.480.830.630.640.64-0.810.751.0-0.52-0.75-0.940.950.470.830.47-0.810.58-0.77-0.210.510.92-0.680.080.990.46
0.591.00.910.880.57-0.970.670.83-0.44-0.67-0.860.750.580.830.58-0.970.47-0.610.210.660.86-0.430.230.860.57
1.00.580.710.750.91-0.60.80.470.05-0.87-0.440.441.00.470.58-0.60.1-0.76-0.160.930.71-0.650.910.441.0
-0.61-0.97-0.95-0.95-0.591.0-0.69-0.810.530.690.87-0.78-0.6-0.81-0.97-0.6-0.590.61-0.23-0.75-0.840.43-0.26-0.82-0.6
0.10.470.470.50.33-0.590.560.58-0.97-0.45-0.780.520.10.580.470.1-0.59-0.49-0.210.360.55-0.48-0.240.590.08
-0.75-0.61-0.55-0.59-0.950.61-0.98-0.770.410.970.78-0.63-0.76-0.77-0.61-0.760.61-0.490.6-0.7-0.930.97-0.49-0.77-0.74
-0.140.210.320.27-0.49-0.23-0.49-0.210.190.450.19-0.08-0.16-0.210.21-0.16-0.23-0.210.60.0-0.30.76-0.11-0.19-0.13
0.930.660.850.90.84-0.750.790.51-0.2-0.84-0.560.520.930.510.660.93-0.750.36-0.70.00.71-0.560.780.470.93
0.720.860.750.760.86-0.840.930.92-0.49-0.93-0.920.80.710.920.860.71-0.840.55-0.93-0.30.71-0.830.370.930.7
-0.64-0.43-0.36-0.4-0.90.43-0.93-0.680.40.910.68-0.52-0.65-0.68-0.43-0.650.43-0.480.970.76-0.56-0.83-0.42-0.67-0.63
0.910.230.450.490.74-0.260.530.080.39-0.63-0.030.090.910.080.230.91-0.26-0.24-0.49-0.110.780.37-0.420.040.91
0.440.860.640.640.61-0.830.750.99-0.56-0.73-0.960.890.440.990.860.44-0.820.59-0.77-0.190.470.93-0.670.040.43
1.00.570.720.750.9-0.60.780.460.07-0.86-0.430.441.00.460.571.0-0.60.08-0.74-0.130.930.7-0.630.910.43
Click cells to compare fundamentals

Mink Therapeutics Account Relationship Matchups

Pair Trading with Mink Therapeutics

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Mink Therapeutics position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Mink Therapeutics will appreciate offsetting losses from the drop in the long position's value.

Moving together with Mink Stock

  0.61VBIV VBI VaccinesPairCorr
The ability to find closely correlated positions to Mink Therapeutics could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Mink Therapeutics when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Mink Therapeutics - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Mink Therapeutics to buy it.
The correlation of Mink Therapeutics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Mink Therapeutics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Mink Therapeutics moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Mink Therapeutics can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Additional Tools for Mink Stock Analysis

When running Mink Therapeutics' price analysis, check to measure Mink Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Mink Therapeutics is operating at the current time. Most of Mink Therapeutics' value examination focuses on studying past and present price action to predict the probability of Mink Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Mink Therapeutics' price. Additionally, you may evaluate how the addition of Mink Therapeutics to your portfolios can decrease your overall portfolio volatility.